Other published data have reported a dysregulation of antioxidant systems in SSc disease, affecting, in particular, the levels of CAT, vitamins C and E, and glutathione (GSH), together with the total antioxidant capacity, which was significantly underrepresented in plasma from SSc patients compared to the controls [162,169,170,171]. This evidence concerns the gene CAT and systemic sclerosis.